Advances in Structural Designs of Chimeric Antigen Receptor T Cells--Review.
10.19746/j.cnki.issn.1009-2137.2022.06.043
- Author:
Pei-Ting YING
1
;
Wen-Wen WENG
1
;
Yong-Min TANG
2
Author Information
1. Department of Hematology-Oncology, The Children's Hospital, Zhejiang University School of Medicine, Pediatric Leukemia Diagnostic and Therapeutic Technology Research Center of Zhejiang Province, National Clinical Research Center for Child Health, Hangzhou 310003, Zhejiang Province, China.
2. Department of Hematology-Oncology, The Children's Hospital, Zhejiang University School of Medicine, Pediatric Leukemia Diagnostic and Therapeutic Technology Research Center of Zhejiang Province, National Clinical Research Center for Child Health, Hangzhou 310003, Zhejiang Province, China .E-mail: y_m_tang@zju.edu.cn.
- Publication Type:Journal Article
- Keywords:
chimeric antigen receptor T cell;
safety;
efficacy;
structural optimization
- MeSH:
Humans;
Receptors, Chimeric Antigen;
T-Lymphocytes
- From:
Journal of Experimental Hematology
2022;30(6):1902-1906
- CountryChina
- Language:Chinese
-
Abstract:
Although chimeric antigen receptor (CAR)-T therapy has produced remarkable clinical responses for patients with relapsed or refractory hematological malignancies, setbacks were experienced, including antigen escape and heterogeneity, its efficacy and safety issues. In recent years, researchers at home and abroad are addressing the current obstacles by digging deeply into structural optimization of CAR gene in order to solve the problems of CAR-T cell therapy. In this review, we mainly illustrate the ectodomain structure, transmemberane domain, and endodomain structure, and new designs which promote persistence of CAR-T cells in vivo, so as to provide new ideas for improving the safety and the efficacy of CAR-T cell therapy.
